Literature DB >> 33183981

Effectiveness of omalizumab in two cases of normocomplementemic urticarial vasculitis due to perivascular mast cell infiltration.

Tomonobu Ito1, Tatsuo Maeda2, Chizu Egusa2, Namiko Abe2, Harutaka Seshimo2, Yukari Okubo2, Kazutoshi Harada2.   

Abstract

Entities:  

Year:  2020        PMID: 33183981     DOI: 10.1016/j.alit.2020.09.012

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


× No keyword cloud information.
  1 in total

1.  Real-World Experience on Omalizumab Treatment for Patients with Normocomplementemic Urticarial Vasculitis.

Authors:  Taoming Liu; Juan Bai; Shuni Ying; Sheng Li; Yunlei Pan; Deren Fang; Jianjun Qiao; Hong Fang
Journal:  J Asthma Allergy       Date:  2021-04-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.